The inhibition of gamma-glutamyl transpeptidase from human pancreatic carcinoma cells by (alpha S,5S) -alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501)
Allen, L.; Meck, R.; Yunis, A.
Research Communications in Chemical Pathology and Pharmacology 27(1): 175-182
1980
ISSN/ISBN: 0034-5164 PMID: 6102405 Document Number: 164205
AT-125, (alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, at a concentration of 5 microM was found to inhibit the growth of human pancreatic carcinoma cells (MIA PaCa-2) by 78% after 72 hours in continuous culture. It was found that MIA PaCa-2 gamma-glutamyl transpeptidase (10 nmol/min/10(6) cells) was irreversibly inactivated by AT-125 with an inactivation half-life of 80 minutes at 450 microM.
Document emailed within 1 workday
Related Documents
Meck, R.A.; Clubb, K.J.; Allen, L.M.; Yunis, A.A. 1981: Inhibition of cell cycle progression of human pancreatic carcinoma cells in vitro by L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, Acivicin (NSC 163501) Cancer Research 41(11 Part 1): 4547-4553Jayaram, H.N.; Ardalan, B.; Deas, M.; Johnson, R.K. 1985: Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin) Cancer Research 45(1): 207-212
Neil, G.L.; Berger, A.E.; McPartland, R.P.; Grindey, G.B.; Bloch, A. 1979: Biochemical and pharmacological effects of the fermentation-derived antitumor agent, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125) Cancer Research 39(3): 852-856
Zabska, R.; Jakóbiec, T.; Dobek, R.; Wilimowski, M.; Barczyńska, J.; Kedzierska-Goździk, L.; Wojewódzki, W.; Rutkowska, M.; Duś, E.; Szelag, A. 1991: Synthesis and pharmacological properties of derivatives of alpha-amino-beta-(p-chlorobenzoyl)-propionic acid and alpha-amino-gamma-(p-chlorophenyl)-tetrahydrofuran-2-one Polish Journal of Pharmacology and Pharmacy 43(4): 271-280
Galerne, D.; Jouanel, P.; Baudon, J.; Dastugue, G. 1970: Several enzyme activities (amylase, acid and alkaline phosphatase and gamma-glutamyl transpeptidase) of human amniotic fluid Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 164(2): 319-324
Takeda, M.; Takagi, T. 1980: Effects of a new bronchodilator, (alpha RS)-3-formamido-4-hydroxy-alpha-[[[(alpha RS)-p-methoxy-alpha-methylphenethyl] amino] methyl] benzyl alcohol fumarate dihydrate (BD 40A) on gastric acid secretion and gastrointestinal motility Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 76(3): 185-191
Mauerhoff, T.; Belfiore, A.; Pujol-Borrell, R.; Bottazzo, G.F. 1994: Growth inhibition of human endothelial cells by human recombinant tumor necrosis factor alpha and interferon-gamma Tumori 80(4): 301-305
Al-Salam, S.; Hameed, R.; Parvez, H.S.; Adeghate, E. 2009: Diabetes mellitus decreases the expression of calcitonin-gene related peptide, gamma-amino butyric acid and glutamic acid decarboxylase in human pancreatic islet cells Neuro Endocrinology Letters 30(4): 506-510
Lisý, V.; Murphy, S. 1984: Gamma-Glutamyl transpeptidase activity can be altered by kainic acid and related compounds Physiologia Bohemoslovaca 33(1): 17-22
Huberman, E.; Montesano, R.; Drevon, C.; Kuroki, T.; St Vincent, L.; Pugh, T.D.; Goldfarb, S. 1979: Gamma-Glutamyl transpeptidase and malignant transformation of cultured liver cells Cancer Research 39(1): 269-272
Satoh, T.; Takenaga, M.; Kitagawa, H.; Itoh, S. 1980: Microassay of gamma-glutamyl transpeptidase in needle biopsies of human liver Research Communications in Chemical Pathology and Pharmacology 30(1): 151-161
Ouwerkerk-Mahadevan, S.; Tirona, R.G.; Ripping, R.A.; Ploemen, J.H.; van Bladeren, P.J.; Pang, K.S.; van Boom, J.H.; Mulder, G.J. 1997: Inhibition of glutathione conjugation by glutathione analogues in the perfused rat liver. Effect of esterification on the potency of gamma-L-glutamyl-alpha-(D-2-aminoadipyl)-N-2-heptylamine Drug Metabolism and Disposition: the Biological Fate of Chemicals 25(10): 1137-1143
Smirne, S.; Ideo, G.; Colombo, M.; Lanzi, G.L. 1974: Serum gamma-glutamyl-transpeptidase and urinary excretion of D-glucaric acid in epileptic patients treated with anticonvulsants Rivista di Neurologia 44(4): 234-238
Tate, S.S.; Galbraith, R.A. 1988: In vitro translation and processing of human hepatoma cell (Hep G2) gamma-glutamyl transpeptidase Biochemical and Biophysical Research Communications 154(3): 1167-1173
Zhang, H.F.; Ong, W.Y.; Leong, S.K.; Laperche, Y. 1997: Species differences in the localisation of gamma-glutamyl transpeptidase immunopositive cells at the blood-brain interface Journal für Hirnforschung 38(3): 323-330
Henson, S.E.; Nichols, T.C.; Holers, V.M.; Karp, D.R. 1999: The ectoenzyme gamma-glutamyl transpeptidase regulates antiproliferative effects of S-nitrosoglutathione on human T and B lymphocytes Journal of Immunology 163(4): 1845-1852
Przybylska, T.; Niewiedziol, B. 1988: Selected aspects of amino acid-protein metabolism in juvenile onset insulin-dependent diabetes mellitus. I. Serum alpha-amino nitrogen level and diurnal urinary excretion of alpha-amino nitrogen and total nitrogen Pediatria Polska 63(1): 20-27
Pardo-Govea, T.; Callejas, D.; Núñez-Troconis, Jé.; Araujo, M.; Costa, L.; Pons, Héctor.; Delgado, M.; Monsalve, F. 2005: Gamma interferon (IFN-gamma), tumor necrosis factor alpha (TNF-alpha) and interleukins 2, 4 and 6 (IL-2, IL-4, IL-6) in cervical-uterine cells of intraepithelial neoplasia: a preliminary report Investigacion clinica 46(1): 5-13
Lisý, V.; Stastný, F.; Lodin, Z. 1983: Gamma-glutamyl transpeptidase activity in isolated cells and in various regions of the mouse brain during early development and aging Physiologia Bohemoslovaca 32(1): 1-9
Raponi, G.; Ghezzi, M.C.; Mancini, C. 1997: The release of tumor necrosis factor alpha (TNF-alpha) by interferon gamma (IFN-gamma) induced THP-1 cells stimulated with smooth lipopolysaccharide is inhibited by MAbs against HLA-DR and CD14 receptors on the effector cell New Microbiologica 20(1): 1-6